The Hindu·4 min read·medium
Make in U.S. by August 2028 or pay up to 200% duty, Trump tells generic drugmakers
N
N. Ravi Kumar
✦AI Summary
U.S. President Donald Trump has announced a new policy requiring generic drugmakers to establish manufacturing facilities in the U.S. by August 2028 or face tariffs of up to 200%. The move aims to reshore pharmaceutical production and reduce reliance on overseas supply chains, though industry leaders warn it could significantly increase medicine costs for American consumers.
U.S. President Donald Trump has given generic pharmaceutical companies a two-year window to establish manufacturing facilities in the United States, warning that products imported after August 2028 could face tariffs of up to 200%.
politicsbusinesshealtheconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in